Migration and immunological reaction after the administration of αgalCer-pulsed antigen-presenting cells into the submucosa of patients with head and neck cancer

Cancer Immunology, Immunotherapy

Volumn 60, Issue 2, 2011, Pages 207-215

  Kurosaki, Motoyoshi ^a   Horiguchi, Shigetoshi ^a   Yamasaki, Kazuki ^a   Uchida, Yoshitaka ^a   Motohashi, Shinichiro ^a   Nakayama, Toshinori ^a   Sugimoto, Akira ^a   Okamoto, Yoshitaka ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Immunotherapy; Migration; Nasal submucosa; Oral submucosa; Vaccine route

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL MIGRATION; CONTROLLED CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG DOSAGE FORM COMPARISON; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LARYNX CANCER; LYMPH NODE; LYMPHOCYTE COUNT; MALE; MAXILLA CANCER; MOUTH CANCER; MOUTH MUCOSA; NATURAL KILLER T CELL; NOSE MUCOSA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; TONGUE CANCER; WHOLE BODY IMAGING;

ADMINISTRATION, MUCOSAL; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD4; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; FEMALE; GALACTOSYLCERAMIDES; HEAD AND NECK NEOPLASMS; HUMANS; LIGANDS; MALE; MIDDLE AGED; MOUTH MUCOSA; NASAL MUCOSA; STAINING AND LABELING; TREATMENT OUTCOME;

EID: 79151481927     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-010-0932-z     Document Type: Article

References (30)

1. G Schuler B Schuler-Thurner RM Steinman 2003 The use of dendritic cells in cancer immunotherapy Curr Opin Immunol 15 138 147 1:CAS:528: DC%2BD3sXhvFaiu7w%3D 10.1016/S0952-7915(03)00015-3 12633662
2. S Horiguchi T Matsuoka Y Okamoto D Sakurai K Kobayashi H Chazono T Hanazawa Y Tanaka 2007 Migration of tumor antigen-pulsed dendritic cells after mucosal administration in the human upper respiratory tract J Clin Immunol 27 6 598 604 10.1007/s10875-007-9112-0 17597385
3. SA Porcelli RL Modlin 1999 The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids Annu Rev Immunol 17 297 329 1:CAS:528:DyaK1MXjtVWgtL0%3D 10.1146/annurev.immunol.17.1.297 10358761
4. M Brigl MB Brenner 2004 CD1: antigen presentation and T cell function Annu Rev Immunol 22 817 890 1:CAS:528:DC%2BD2cXktlOgsbo%3D 10.1146/annurev. immunol.22.012703.104608 15032598
5. T Kawano T Nakayama N Kamada Y Kaneko M Harada N Ogura Y Akutsu S Motohashi T Iizasa H Endo T Fujisawa H Shinkai M Taniguchi 1999 Antitumor cytotoxicity mediated by ligand-activated human Va24 NKT cells Cancer Res 59 5102 5105 1:CAS:528:DyaK1MXmvFelsrk%3D 10537282
6. T Uchida S Horiguchi Y Tanaka H Yamamoto N Kunii S Motohashi M Taniguchi T Nakayama Y Okamoto 2008 Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer Cancer Immunol Immunother 57 337 345 1:CAS:528:DC%2BD2sXhsVGhurvE 10.1007/s00262-007-0373-5 17690880
7. N Kunii S Horiguchi S Motohashi H Yamamoto N Ueno S Yamamoto D Sakurai M Taniguchi T Nakayama Y Okamoto 2009 Combination therapy of in vitro-expanded natural killer T cells and alpha-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma Cancer Science 100 1092 1098 1:CAS:528:DC%2BD1MXntlSjtbo%3D 10.1111/j.1349-7006.2009.01135.x 19302288
8. S Motohashi S Kobayashi T Ito KK Magara O Mikuni N Kamada T Iizasa T Nakayama T Fujisawa M Taniguchi 2003 Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients Int J Cancer 102 2 159 165 10.1002/ijc.10678
9. L Strauss TL Whiteside A Knights C Bergmann A Knuth A Zippelius 2007 Selective survival of naturally occurring human CD4+ CD25+ Foxp3+ regulatory T cells cultured with rapamycin J Immunol 178 1 320 329 1:CAS:528:DC%2BD2sXnvVWn 17182569
10. W Liu AL Putnam X Zhou GL Szot MR Lee S Zhu PA Gottlieb P Kapranov TR Gingeras BF de St. Groth C Clayberger DM Soper SF Ziegler JA Bluestone 2006 CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells J Exp Med 203 7 1701 1711 1:CAS:528:DC%2BD28XntVCgs70%3D 10.1084/jem.20060772 16818678
11. L Illum SS Davis 2001 Nasal vaccination: a non-invasive vaccine delivery method that holds great promise for the future Adv Drug Deliv Rev 51 1-3 1 3 1:CAS:528:DC%2BD3MXmtV2ntL0%3D 11516775
12. PM Mendelman J Cordova I Cho 2001 Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults Vaccine 19 17-19 2221 2226 1:STN:280:DC%2BD3MvgvFSmtQ%3D%3D 10.1016/S0264-410X(00)00449-7 11257337
13. RB Belshe KL Nichol SB Black H Shinefield J Cordova R Walker C Hessel I Cho PM Mendelman 2004 Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years Clin Infect Dis 39 7 920 927 10.1086/423001 15472840
14. P Moingeon T Batard R Fadel F Frati J Sieber L Van Overtvelt 2006 Immune mechanisms of allergen-specific sublingual immunotherapy Allergy 61 2 151 165 1:CAS:528:DC%2BD28Xit12hurc%3D 10.1111/j.1398-9995.2006.01002.x 16409190
15. T Aoyama-Kondo T Yoshida K Tsobe A Nakayama J Asai T Oka I Nakashima 1992 Characterization of antibody responses of local lymph nodes to antigen given under the oral submucosa Immunobiology 184 4-5 372 383 1:STN:280: DyaK383nsFKmsA%3D%3D 1592428
16. JM van Helvoort JN Samsom D Chantry W Jansen I Schadee-Eestermans T Thepen RE Mebius G Kraal 2004 Preferential expression of IgG2b in nose draining cervical lymph nodes and its putative role in mucosal tolerance induction Allergy 59 11 1211 1218 10.1111/j.1398-9995.2004.00510.x 15461604
17. JM Coquet S Chakravarti K Kyparissoudis FW McNab LA Pitt BS McKenzie SP Berzins MJ Smyth DI Godfrey 2008 Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population Proc Natl Acad Sci USA 105 32 11287 11292 1:CAS:528:DC%2BD1cXhtVShurfP 10.1073/pnas.0801631105 18685112
18. S Fujii K Shimizu H Hemmi RM Steinman 2007 Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity Immunol Rev 220 183 198 1:CAS:528:DC%2BD2sXhsVKgtrvO 10.1111/j.1600-065X.2007. 00561.x 17979847
19. M Goto M Murakawa K Kadoshima-Yamaoka Y Tanaka K Nagahira Y Fukuda T Nishimura 2009 Murine NKT cells produce Th17 cytokine interleukin-22 Cell Immunol 254 2 81 84 1:CAS:528:DC%2BD1cXhsV2gt7%2FL 10.1016/j.cellimm.2008.10.002 19010461
20. H Kitamura A Ohta M Sekimoto M Sato K Iwakabe M Nakui T Yahata H Meng T Koda S Nishimura T Kawano M Taniguchi T Nishimura 2000 alpha-Galactosylceramide induces early B-cell activation through IL-4 production by NKT cells Cell Immunol 199 1 37 42 1:CAS:528:DC%2BD3cXhtFWjsrY%3D 10.1006/cimm.1999.1602 10675273
21. JB Sun N Cuburu M Blomquist BL Li C Czerkinsky J Holmgren 2006 Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+ CD25+ CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions Scand J Immunol 64 3 251 259 1:CAS:528: DC%2BD28XhtVCmsLfO 10.1111/j.1365-3083.2006.01823.x 16918694
22. JB Sun C Czerkinsky J Holmgren 2007 Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells Scand J Immunol 66 2-3 278 286 1:CAS:528:DC%2BD2sXpvVGqtrs%3D 10.1111/j.1365-3083.2007.01975.x 17635805
23. P Pandiyan L Zheng S Ishihara J Reed MJ Lenardo 2007 CD4+ CD25+ Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells Nat Immunol 8 12 1353 1362 1:CAS:528:DC%2BD2sXhtlajtr7E 10.1038/ni1536 17982458
24. H1 and regulatory CD4+ T cells J Allergy Clin Immunol 122 3 603 609 1:CAS:528:DC%2BD1cXhtVyku7vI 10.1016/j.jaci.2008.06.034 18774396
25. B Bohle T Kinaciyan M Gerstmayr A Radakovics B Jahn-Schmid C Ebner 2007 Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation J Allergy Clin Immunol 120 3 707 713 1:CAS:528:DC%2BD2sXhtVSgsbzE 10.1016/j.jaci.2007.06.013 17681368
26. JH Song HH Nguyen N Cuburu T Horimoto SY Ko SH Park C Czerkinsky MN Kweon 2008 Sublingual vaccination with influenza virus protects mice against lethal viral infection Proc Natl Acad Sci USA 105 5 1644 1649 1:CAS:528: DC%2BD1cXhvFWrt70%3D 10.1073/pnas.0708684105 18227512
27. AW Burks S Laubach SM Jones 2008 Oral tolerance, food allergy and immunotherapy: implications for future treatment J Allergy Clin Immunol 121 6 1344 1350 1:CAS:528:DC%2BD1cXmvV2ktLo%3D 10.1016/j.jaci.2008.02.037 18410959
28. La Cava A, Van Kaer L, Fu-Dong-Shi (2006) CD4+ CD25+ Tregs and NKT cells: regulators regulating regulators. Trends Immunol 27(7):322-327
29. S Jiang DS Game D Davies G Lombardi RI Lechler 2005 Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4+ CD25+ regulatory T cells? Eur J Immunol 35 4 1193 1200 1:CAS:528:DC%2BD2MXjslSgtbo%3D 10.1002/eji.200425899 15770696
30. T Azuma T Takahashi A Kunisato T Kitamura H Hirai 2003 Human CD4+ CD25+ regulatory T cells suppress NKT cell functions Cancer Res 63 15 4516 4520 1:CAS:528:DC%2BD3sXmtFers78%3D 12907625